Our Science

Having an active immune system is essential when it comes to fighting off infectious diseases. Vaccines can enhance our immune response by activating a T-cell response and by producing neutralizing antibodies to invading viruses. Neutralizing antibodies are an essential defense mechanism and block viruses from entering our host cells while T-cells are also important for the limiting and clearing of viral infections. With these tools, our body is able to get a head start on fighting off viral infection.

Messanger RNA (mRNA) is an essential component for living organisms. Its role is to deliver instructions to the cells to notify them to make certain proteins. These proteins can be used by the immune system to help them fight infectious diseases. Once it provides instructions to the cells, it is broken down and leaves the body.

In order for mRNA to enter our cells, it must be encapsulated in a LNP. mRNA vaccines are composed of mRNA wrapped inside of a LNP, the efficacy of this process is essential in creating an effective and safe vaccine. A more effective LNP is correlated to lower side effects and lower cost. We have successfully identified and patented a novel Lipid Nanoparticle (LNP), ARV-L002 LNP that outperforms its competitors by delivering mRNA with exceptional efficiency, surpassing current standards by a remarkable 100 times. This cutting-edge LNP holds immense promise for revolutionizing the landscape of safe vaccine development, gene therapy, and other related applications.

Platforms